基于专利信息的我国干细胞产业技术竞争态势研究  

Study on the Technology Competition Trend of Stem Cell Industry Based on the Patent Information

作　　者：高翔[1,2] 王宏起[1] 武建龙[1] 

机构地区：[1]哈尔滨理工大学管理学院,黑龙江哈尔滨150080 [2]哈尔滨埃文斯干细胞应用技术有限公司,黑龙江哈尔滨150025

出　　处：《科技管理研究》2015年第7期136-140,共5页Science and Technology Management Research

基　　金：国家自然科学基金项目"区域战略性新兴产业综合优势理论方法与实证研究"(71173062);教育部人文社会科学基金项目"基于模块化的战略性新兴产业突破性技术创新路径与管理方法研究"(12YJC630238);黑龙江省青年科学基金项目"区域高端装备制造业技术模块化创新路径与管理方法研究"(QC2014C084);黑龙江省高校哲学社会科学学术创新团队建设计划项目"哈尔滨理工大学高新技术发展与战略管理创新团队"(TD201203)

摘　　要：通过中国专利数据库公开的发明专利信息,采用专利地图和专利计量分析方法对我国干细胞产业技术竞争态势进行系统分析与比较。结果表明,我国干细胞产业专利技术增长强劲,美国、日本、韩国等发达国家是我国在干细胞领域的竞争者;我国干细胞技术优势主要集中在科研机构和大学,国内研发团队领军人才明显少于国外机构,国内专利技术质量也不及国外。研究旨在为我国干细胞产业专利战略和产业创新政策的制定提供决策参考。Through the invention patent information disclosed in the China patent database,and using the patent maps and patent -bibliometric analysis methods,the paper systematically analyzes and compares the competition trend of stem cell industry in our country,from the aspects of overall development trend,regional distribution trend,innovation subject com-petition advantage,R ＆amp;D team efficiency,R ＆amp;D hot points and technology relevance etc.The research shows that,the quantity growth of stem cell industry patent technology in our country is strong,and our main competitors are from devel-oped countries such as America,Japan and South Korea;the research advantage of research institution and university is stronger than the enterprises in China;our leader talent of R ＆amp;D team is far fewer than other countries,and China＇s patent quality is lower.This research is to provide decision reference for patent strategy and related industrial policy construction of stem cell industry in our country.

关 键 词：干细胞产业 产业技术 专利信息 技术创新 

分 类 号：Q2-3[生物学—细胞生物学]